A double-blind, double-dummy, randomized controlled, multicenter trial of 99Tc-methylene diphosphonate in patients with moderate to severe rheumatoid arthritis
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine,General Medicine
Reference20 articles.
1. Rheumatoid arthritis;Smolen;Lancet,2016
2. Treatment strategies are more important than drugs in the management of rheumatoid arthritis;Drosos;Clin Rheumatol,2020
3. Efficacy and safety of tofacitinib in Chinese patients with rheumatoid arthritis;Li;Chin Med J,2018
4. Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study;Wollenhaupt;Arthritis Res Ther,2019
5. Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension;Burmester;RMD Open,2019
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Observation of the Short-term Efficacy of Technetium-99 Conjugated with Methylene Diphosphonate Combined Therapy in the Treatment of Postmenopausal Osteoporosis;Combinatorial Chemistry & High Throughput Screening;2024-08
2. 16S rRNA Gene Sequencing of Gut Microbiota in Rheumatoid Arthritis Treated with 99Tc-MDP;Pharmacogenomics and Personalized Medicine;2024-05
3. Effectiveness and safety of 99Tc-methylene diphosphonate as a disease-modifying anti-rheumatic drug (DMARD) in combination with conventional synthetic (cs) DMARDs in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of 34 randomized controlled trials;Heliyon;2023-11
4. Traditionelle chinesische Medizin – Relevant für die Behandlung der rheumatoiden Arthritis?;Aktuelle Rheumatologie;2023-08-30
5. Effectiveness and Safety of 99tc-Methylene Diphosphonate as a Disease-Modifying Anti-Rheumatic Drug (DMARD) in Combination with Conventional Synthetic (cs) DMARDs in the Treatment of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 34 Randomized Controlled Trials;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3